Leidos Holdings, Inc., together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. It operates through three segments: Defense Solutions, Civil, and Health. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S. Intelligence Community, the Department of Defense, the National Aeronautics and Space Administration, military services, and government agencies of U.S. allies abroad, as well as other federal and commercial customers in the national security industry. Its solutions include technology, large-scale systems, command and control platforms, data analytics, logistics, and cybersecurity solutions, as well as intelligence analysis and operations support services to critical missions. The Civil segment provides systems integration services to air navigation service providers, including the federal aviation administration, the En route automation modernization, advanced technology oceanic procedure, time based flow management, terminal flight data management, geo-7, and future flight services, as well as enterprise-information display systems; and security detection and automation services. It also offers information technology (IT) solutions in cloud computing, mobility, application modernization, DevOps, data center, network modernization, asset management, help desk operations, and digital workplace enablement; and environment, energy, and infrastructure services. The Health segment offers solutions to federal and commercial customers responsible for health and well-being of people worldwide, including health information management, managed health, digital transformation, and life sciences research and development services. Leidos Holdings, Inc. was founded in 1969 and is headquartered in Reston, Virginia.
Leidos Price Performance
Shares of NYSE:LDOS opened at $100.97 on Tuesday. The business's 50 day simple moving average is $100.44 and its 200-day simple moving average is $101.28. The firm has a market capitalization of $13.79 billion, a price-to-earnings ratio of 19.65, a price-to-earnings-growth ratio of 2.28 and a beta of 0.71. The company has a debt-to-equity ratio of 0.99, a current ratio of 0.90 and a quick ratio of 0.83. Leidos has a 12 month low of $81.07 and a 12 month high of $111.12.
Leidos (NYSE:LDOS - Get Rating) last posted its earnings results on Tuesday, August 2nd. The aerospace company reported $1.59 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.55 by $0.04. Leidos had a return on equity of 22.18% and a net margin of 5.15%. The firm had revenue of $3.60 billion for the quarter, compared to analyst estimates of $3.52 billion. During the same quarter in the prior year, the company earned $1.52 EPS. Leidos's revenue was up 4.3% on a year-over-year basis. As a group, equities analysts forecast that Leidos will post 6.36 earnings per share for the current fiscal year.
Leidos Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, September 30th. Investors of record on Thursday, September 15th will be paid a $0.36 dividend. This represents a $1.44 dividend on an annualized basis and a yield of 1.43%. The ex-dividend date of this dividend is Wednesday, September 14th. Leidos's payout ratio is currently 27.96%.
Wall Street Analyst Weigh In
Several research firms have issued reports on LDOS. Truist Financial boosted their target price on Leidos from $108.00 to $120.00 in a research report on Wednesday, May 4th. Barclays cut Leidos from an "overweight" rating to an "equal weight" rating and set a $105.00 target price on the stock. in a research report on Tuesday, June 7th. Wells Fargo & Company dropped their target price on Leidos from $109.00 to $105.00 and set an "equal weight" rating on the stock in a research report on Wednesday, August 3rd. Finally, Morgan Stanley boosted their price target on Leidos from $107.00 to $110.00 and gave the stock an "equal weight" rating in a research note on Wednesday, August 3rd. Four investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $113.00.
Insider Activity at Leidos
In other Leidos news, insider James Robert Moos sold 516 shares of the stock in a transaction on Wednesday, June 15th. The stock was sold at an average price of $98.56, for a total transaction of $50,856.96. Following the transaction, the insider now owns 21,391 shares of the company's stock, valued at approximately $2,108,296.96. The sale was disclosed in a filing with the SEC, which is available at the SEC website. In other Leidos news, insider James Robert Moos sold 516 shares of the stock in a transaction on Wednesday, June 15th. The stock was sold at an average price of $98.56, for a total transaction of $50,856.96. Following the transaction, the insider now owns 21,391 shares of the company's stock, valued at approximately $2,108,296.96. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Harry M. Jansen Kraemer, Jr. sold 7,274 shares of the stock in a transaction on Thursday, May 26th. The stock was sold at an average price of $103.18, for a total value of $750,531.32. Following the transaction, the director now directly owns 84,277 shares in the company, valued at approximately $8,695,700.86. The disclosure for this sale can be found here. 1.67% of the stock is owned by corporate insiders.
